Share on LinkedInShare on LinkedIn

ARTICLE · 27 AUGUST 2019

Haug Partners Defeats Indirect Purchasers' Class Certification Motion On Behalf Of Shire Defendants

On August 21, 2019, Judge Allison Burroughs of the U.S. District Court for the District of Massachusetts issued an opinion and order

United StatesConsumer Protection

On August 21, 2019, Judge Allison Burroughs of the U.S. District Court for the District of Massachusetts issued an opinion and order denying proposed consumer classes in the matter captioned In re Intuniv Antitrust Litigation. The In re Intuniv Antitrust Litigation consists of two separate cases, one brought by direct purchasers of branded and generic Intuniv® (extended release guanfacine hydrochloride), the other brought by consumers of the drug (indirect purchasers). In both cases, the plaintiffs allege that Shire (Takeda) and Actavis (Teva) settled Intuniv patent litigation via an unlawful pay-for-delay settlement which the plaintiffs claim delayed competition in brand and generic Intuniv, resulting in higher prices. The Court denied the Indirect Purchaser Plaintiffs' Motion for Class Certification. The Court has not yet issued a ruling on the Direct Purchaser Plaintiffs' motion.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from